Clinical trial

Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant…

NCT00427076 · Rabin Medical Center, Other · Completed

Key facts

NCT number NCT00427076
Title Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections
Official title Treatment With Cotrimoxazole vs. Vancomycin for Infections Caused by Methicillin-resistant Staphylococcus Aureus: Randomized Controlled Trial
Lead sponsor Rabin Medical Center, Other
Status Completed
Phase Phase 3
Study type Interventional
Conditions Staphylococcal Infections, Meningitis, Sepsis, Pneumonia
Intervention type Drug
Interventions Cotrimoxazole, Vancomycin
Enrollment 252
Start date Jun 1, 2007
Primary completion May 1, 2014
Completion Jun 1, 2014
First posted Jan 26, 2007
Last update posted Sep 25, 2015
Countries Israel

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies